Previous studies have associated DNMT1 overexpression with tumorigenesis and metastasis in various cancers [18, 69], and RASSF1A promoter hypermethylation has been implicated in its transcriptional silencing across multiple tumor types [21, 70]. Here, RASSF1 is linked to neoplasm.